 | • レポートコード：MRC22iR11015 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、235ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療 |
| Single User | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Five User | ￥880,452 (USD5,949) | ▷ お問い合わせ |
| Enterprise License | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートは、2021年に228.2億ドルであった世界のポイントオブケア検査（POCT）市場規模が、2022年に256.7億ドルになり、2027年まで年平均12.65%で成長して466.4億ドルに達すると予測しています。本レポートでは、ポイントオブケア検査（POCT）の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場洞察、製品別（心臓代謝モニタリングキット、コレステロール試験紙、不妊治療＆妊娠検査キット、グルコースモニタリングキット、血液検査キット）分析、エンドユーザー別（外来治療、在宅医療、病院＆救命救急、外来患者、研究機関）分析、地域別（南北アメリカ、アジア太平洋、ヨーロッパ）分析、競争状況、企業情報などの項目を掲載しています。本書ではAbbott Laboratories、ACON Laboratories, Inc.、Alere Inc、Ativa Medical Corporation、Becton, Dickinson, and Company、BIOMERIEUX SA、Chembio Diagnostics、Danaher Corporation、EKF Diagnostics Holdings plc、Henry Schein, Inc、Informa PLC、Instrumentation Laboratory Company、Johnson and Johnson Service, Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場洞察 ・世界のポイントオブケア検査（POCT）市場規模：製品別 - 心臓代謝モニタリングキットの市場規模 - コレステロール試験紙の市場規模 - 不妊治療＆妊娠検査キットの市場規模 - グルコースモニタリングキットの市場規模 - 血液検査キットの市場規模 ・世界のポイントオブケア検査（POCT）市場規模：エンドユーザー別 - 外来治療における市場規模 - 在宅医療における市場規模 - 病院＆救命救急における市場規模 - 外来患者における市場規模 - 研究機関における市場規模 ・世界のポイントオブケア検査（POCT）市場規模：地域別 - 南北アメリカのポイントオブケア検査（POCT）市場規模 - アジア太平洋のポイントオブケア検査（POCT）市場規模 - ヨーロッパのポイントオブケア検査（POCT）市場規模 ・競争状況 ・企業情報 |
The Global Point of Care Testing Market size was estimated at USD 22.82 billion in 2021 and expected to reach USD 25.67 billion in 2022, and is projected to grow at a CAGR 12.65% to reach USD 46.64 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Point of Care Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Cardio-metabolic Monitoring Kits, Cholesterol Test Strips, Fertility and Pregnancy Testing Kits, Glucose Monitoring Kits, Haematology Testing Kits, and Infectious Disease Testing Kits.
Based on End User, the market was studied across Ambulatory Care, Home Care, Hospitals or Critical Care, Outpatient Healthcare, and Research Laboratories.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Point of Care Testing market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Point of Care Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Point of Care Testing Market, including Abbott Laboratories, ACON Laboratories, Inc., Alere Inc, Ativa Medical Corporation, Becton, Dickinson, and Company, BIOMERIEUX SA, Chembio Diagnostics, Danaher Corporation, EKF Diagnostics Holdings plc, Henry Schein, Inc, Informa PLC, Instrumentation Laboratory Company, Johnson and Johnson Service, Inc., Medtronic plc, Polymer Technology Systems, Inc., QIAGEN GmbH, Roche Holding AG, Siemens AG, Sienco, Inc., and WerfenLife, S.A..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Point of Care Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Point of Care Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Point of Care Testing Market?
4. What is the competitive strategic window for opportunities in the Global Point of Care Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Point of Care Testing Market?
6. What is the market share of the leading vendors in the Global Point of Care Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Point of Care Testing Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of chronic and infectious diseases globally
5.1.1.2. Favorable government policies for introduction of POC testing
5.1.1.3. Potential demand for enhanced patient-centric care with new advanced testing kits
5.1.2. Restraints
5.1.2.1. Relatively high cost involved in product development
5.1.3. Opportunities
5.1.3.1. Surge in research and development investment by manufacturers
5.1.3.2. Technological advancements in POC testing
5.1.4. Challenges
5.1.4.1. Strict regulatory policies for approval of POC testing kits
5.2. Cumulative Impact of COVID-19
6. Point of Care Testing Market, by Product
6.1. Introduction
6.2. Cardio-metabolic Monitoring Kits
6.3. Cholesterol Test Strips
6.4. Fertility and Pregnancy Testing Kits
6.5. Glucose Monitoring Kits
6.6. Haematology Testing Kits
6.7. Infectious Disease Testing Kits
7. Point of Care Testing Market, by End User
7.1. Introduction
7.2. Ambulatory Care
7.3. Home Care
7.4. Hospitals or Critical Care
7.5. Outpatient Healthcare
7.6. Research Laboratories
8. Americas Point of Care Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Point of Care Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Point of Care Testing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Abbott Laboratories
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. ACON Laboratories, Inc.
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Alere Inc
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Ativa Medical Corporation
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Becton, Dickinson, and Company
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. BIOMERIEUX SA
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Chembio Diagnostics
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Danaher Corporation
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. EKF Diagnostics Holdings plc
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Henry Schein, Inc
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Informa PLC
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Instrumentation Laboratory Company
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Johnson and Johnson Service, Inc.
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Medtronic plc
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Polymer Technology Systems, Inc.
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. QIAGEN GmbH
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Roche Holding AG
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Siemens AG
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Sienco, Inc.
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. WerfenLife, S.A.
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 2. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 4. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. GLOBAL POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL POINT OF CARE TESTING MARKET DYNAMICS
FIGURE 11. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 12. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2027
FIGURE 14. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIO-METABOLIC MONITORING KITS, 2018-2027 (USD BILLION)
FIGURE 15. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CHOLESTEROL TEST STRIPS, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FERTILITY AND PREGNANCY TESTING KITS, 2018-2027 (USD BILLION)
FIGURE 17. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GLUCOSE MONITORING KITS, 2018-2027 (USD BILLION)
FIGURE 18. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HAEMATOLOGY TESTING KITS, 2018-2027 (USD BILLION)
FIGURE 19. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING KITS, 2018-2027 (USD BILLION)
FIGURE 20. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 21. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
FIGURE 22. GLOBAL POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 23. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE, 2018-2027 (USD BILLION)
FIGURE 24. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, 2018-2027 (USD BILLION)
FIGURE 25. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS OR CRITICAL CARE, 2018-2027 (USD BILLION)
FIGURE 26. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OUTPATIENT HEALTHCARE, 2018-2027 (USD BILLION)
FIGURE 27. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2027 (USD BILLION)
FIGURE 28. AMERICAS POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 29. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 30. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 31. AMERICAS POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 32. ARGENTINA POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 33. BRAZIL POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 34. CANADA POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 35. MEXICO POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 36. UNITED STATES POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 37. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 38. UNITED STATES POINT OF CARE TESTING MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 39. UNITED STATES POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 40. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 42. ASIA-PACIFIC POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 43. ASIA-PACIFIC POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 44. AUSTRALIA POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 45. CHINA POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 46. INDIA POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 47. INDONESIA POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 48. JAPAN POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. MALAYSIA POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 50. PHILIPPINES POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 51. SINGAPORE POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 52. SOUTH KOREA POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 53. TAIWAN POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 54. THAILAND POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. VIETNAM POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 60. DENMARK POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. EGYPT POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. FINLAND POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. FRANCE POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. GERMANY POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. ISRAEL POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 66. ITALY POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 67. NETHERLANDS POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 68. NIGERIA POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 69. NORWAY POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 70. POLAND POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 71. QATAR POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 72. RUSSIA POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 73. SAUDI ARABIA POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 74. SOUTH AFRICA POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 75. SPAIN POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 76. SWEDEN POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 77. SWITZERLAND POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 78. TURKEY POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 79. UNITED ARAB EMIRATES POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 80. UNITED KINGDOM POINT OF CARE TESTING MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 81. GLOBAL POINT OF CARE TESTING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 82. GLOBAL POINT OF CARE TESTING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 83. GLOBAL POINT OF CARE TESTING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021